Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.62766675
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...

229.25 1.01 (0.44%)

84.79% Gain from 52W Low

754.7K

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.7 / 100

Technically Neutral

59.4 / 100

291

1Yr Price target upside is 27%

16 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..